Polish Biotech Database

News in the Life Sciences Industry
Results 1 - 20 out of 25 displayed.
1 2 »

Celon Pharma Files for Approval of Phase II Trial of CPL’280, a Second Generation GPR40 Agonist, in Type 2 Diabetes

By: GlobenewsWire - 22 Jun 2021

Related companies: Celon Pharma S.A.

European Commission approves Aubagio® (teriflunomide) as the first oral MS therapy for first-line treatment of children and adolescents living with relapsing-remitting multiple sclerosis

By: GlobenewsWire - 18 Jun 2021

Gilead Sciences Announces Subanalyses of Safety and Efficacy Data from a Phase 2 Study of Chronic Hepatitis B Patients with Renal or Hepatic Impairment Switching to Vemlidy(r)

-- Data Presented at the Global Hepatitis Summit Show that Virally Suppressed Patients from Taiwan with Renal or Hepatic Impairment had High Rates of Viral Suppression and Improved or Stable Bone and Renal Parameters, Following Switching to Vemlidy® -- Read more ››

By: PR Newswire Association LLC. - 18 Jun 2021

New pivotal data at EHA 2021 reinforces sutimlimab as a first-in-class investigational C1s inhibitor with the potential to be the first approved treatment for hemolysis in people with CAD, a serious and chronic autoimmune hemolytic anemia

By: GlobenewsWire - 11 Jun 2021

Phosplatin Therapeutics to Present at 2021 BIO Digital

By: PR Newswire Association LLC. - 10 Jun 2021

Results from Qu Biologics’ Crohn’s Disease RESTORE Trial Selected for Oral Presentation at ECCO 2021

By: GlobenewsWire - 09 Jun 2021

Sanofi launches its new global employee share ownership plan

By: GlobenewsWire - 07 Jun 2021

Sanofi launches €3 million Planet Mobilization fund to support employees’ environmental projects

By: GlobenewsWire - 03 Jun 2021

Zimmer Biomet's ROSA Knee System awarded Orthopaedic Product Innovation of the Year at the recently concluded Healthcare Asia Medtech Awards 2021.

By: PR Newswire Association LLC. - 28 May 2021

Sanofi and GSK initiate global Phase 3 clinical efficacy study of COVID-19 vaccine candidate

By: GlobenewsWire - 27 May 2021

Qu Biologics Files Important New IP for the Treatment of Post-Surgical Immune Dysfunction and Prevention of Cancer Metastasis

By: GlobenewsWire - 12 May 2021

Lambda makes a critical contribution in the fight against COVID-19

By: PR Newswire Association LLC. - 03 May 2021

Related companies: Lambda Therapeutic Research Ltd. | Lambda Therapeutic Research Sp. z o.o. | Lambda Therapeutic Research | Lambda Therapeutic Research, Inc.

Celon Pharma Hosting a Virtual Capital Markets Day on Wednesday, April 21st

By: GlobenewsWire - 19 Apr 2021

Related companies: Celon Pharma S.A.

Ryvu Announces Partial Clinical Hold of Phase Ib Clinical Trial of RVU120 (SEL120) in Acute Myeloid Leukemia and Myelodysplastic Syndrome

By: PR Newswire Association LLC. - 08 Apr 2021

Related companies: Ryvu Therapeutics

Celon Pharma Announces CPL’280, Second Generation Oral GPR40 Agonist, Meets Primary Endpoint in Phase 1 Trial

By: GlobenewsWire - 01 Apr 2021

Related companies: Celon Pharma S.A.

Ryvu Therapeutics reports financial results for 2020

By: PR Newswire Association LLC. - 16 Mar 2021

Related companies: Ryvu Therapeutics

Baxter, a global leader in kidney care, reaffirms its commitment to equitable access to care on World Kidney Day

By: PR Newswire Association LLC. - 11 Mar 2021

Baxter Announces New Data on Benefits of Remote Patient Management for Home Peritoneal Dialysis World Kidney Day 11 March 2021

By: PR Newswire Association LLC. - 11 Mar 2021

Baxter, a global partner of World Kidney Day welcomes new guidance issued by Vietnam Ministry of Health for End Stage Renal Disease (ESRD) Patients

By: PR Newswire Association LLC. - 11 Mar 2021

Baxter, a global leader in Dialysis Care, reaffirms its commitment to equitable access to care on World Kidney Day

By: PR Newswire Association LLC. - 11 Mar 2021

1 2 »

Looking for companies outside of Poland?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

June 2021
- BioTrinity 2021
July 2021
- BIO Asia-Taiwan
August 2021
- Biotechgate Digital Partnering

See Events »

Add an Event »

Latest company news

Celon Pharma Files for Approval of Phase II Trial of CPL’280, a Second Generation GPR40 Agonist, in Type 2 Diabetes
22 Jun 2021 (GlobenewsWire)

European Commission approves Aubagio® (teriflunomide) as the first oral MS therapy for first-line treatment of children and adolescents living with relapsing-remitting multiple sclerosis
18 Jun 2021 (GlobenewsWire)

Gilead Sciences Announces Subanalyses of Safety and Efficacy Data from a Phase 2 Study of Chronic Hepatitis B Patients with Renal or Hepatic Impairment Switching to Vemlidy(r)
18 Jun 2021 (PR Newswire Association LLC.)

News in the Life Sciences Industry

Looking for companies outside of Poland?

Partners

Upcoming Life Sciences Events

Latest company news